You don’t have to white-knuckle your way through postpartum depression.
TMS (transcranial magnetic stimulation) is an FDA-cleared, non-drug treatment for Major Depressive Disorder. For new mothers whose depression hasn’t improved with medication — or who need a different path — it’s worth a conversation with a psychiatric provider.
Postpartum depression is not itself a separate FDA-cleared indication for TMS — DTIP’s TMS treatment is cleared for Major Depressive Disorder (MDD) in adults who have not responded well to prior antidepressant treatment. Full scope below.
✓ In-Network with Ambetter & BCBS
✓ Non-Drug Treatment Option
✓ Provider-Led Care Plan
Postpartum depression is common, and it is not a reflection of your ability as a parent. If the early weeks or months with your baby haven’t felt the way you expected, you are not alone — and there are real, treatable reasons for what you’re feeling.
This is more than the “baby blues.”
Postpartum depression (PPD) is a form of Major Depressive Disorder that develops during pregnancy or in the months after delivery. It’s one of the most common complications of childbirth, and it’s driven by a real mix of hormonal shifts, sleep deprivation, and life change — not a character flaw or a lack of love for your baby.
The “baby blues” — tearfulness, mood swings, and overwhelm in the first couple of weeks after delivery — are common and usually fade on their own. Postpartum depression is different: it tends to last longer, feels heavier, and can make it hard to function day to day. Symptoms can include:
- Persistent sadness, emptiness, or hopelessness most of the day
- Loss of interest in things you used to enjoy, including time with your baby
- Trouble sleeping even when your baby is asleep, or sleeping far more than usual
- Intense irritability, anxiety, or guilt
- Difficulty concentrating, making decisions, or completing everyday tasks
- Feeling disconnected from your baby, or doubting your ability to care for them
How TMS may help — and where the evidence stands
TMS is FDA-cleared for the “treatment of depressive episodes, and decreasing anxiety symptoms in patients with comorbid anxiety, in adults with Major Depressive Disorder who failed to improve on prior antidepressant treatment.” Postpartum depression is a form of Major Depressive Disorder, so it falls within that broader clearance — TMS is not FDA-cleared under a separate “postpartum depression” indication.
At DTIP, we use the MagVenture TMS Therapy System (MagPro stimulator with Cool-B65/Cool-B70 coils). Treatment is delivered under our standard MDD protocol — a psychiatric evaluation, brain mapping to locate your individual treatment site, and ongoing provider oversight throughout your sessions. It’s a non-drug option: TMS uses magnetic pulses to stimulate areas of the brain involved in mood regulation, rather than a medication that circulates through your body.
What the published research says
A small but growing body of research has looked specifically at TMS for peripartum and postpartum depression. Here’s a fair summary of that research, including its limits:
A 2021 systematic review and meta-analysis pooled the available studies on repetitive TMS for peripartum depression and found a significant therapeutic effect, with no severe side effects reported for mothers or infants across the studies reviewed. The authors were clear that further research is needed before confidence in these results can be considered strong.
According to PubMed: Lee HJ, Kim SM, Kwon JY. “Repetitive transcranial magnetic stimulation treatment for peripartum depression: systematic review & meta-analysis.” BMC Pregnancy Childbirth. 2021;21(1):118. DOI: 10.1186/s12884-021-03600-3
A 2019 exploratory pilot study followed six women receiving TMS for postpartum depression and found sustained improvement in depression and anxiety scores at three- and six-month follow-up. This was a small, uncontrolled study with no sham (placebo) comparison arm, so its findings point toward a promising direction rather than proof of effect.
According to PubMed: Cox EQ, Killenberg S, Frische R, McClure R, Hill M, Jenson J, Pearson B, Meltzer-Brody SE. “Repetitive transcranial magnetic stimulation for the treatment of postpartum depression.” J Affect Disord. 2019;264:193-200. DOI: 10.1016/j.jad.2019.11.069
A 2020 systematic review and meta-analysis of randomized controlled trials examined TMS’s effects on depression symptoms and cognitive function specifically in postpartum depression, adding to the growing but still limited body of controlled research in this population.
According to PubMed: Peng L, Fu C, Xiong F, Zhang Q, Liang Z, Chen L, He C, Wei Q. “Effects of repetitive transcranial magnetic stimulation on depression symptoms and cognitive function in treating patients with postpartum depression: A systematic review and meta-analysis of randomized controlled trials.” Psychiatry Res. 2020;290:113124. DOI: 10.1016/j.psychres.2020.113124
An honest note on the evidence
TMS’s FDA clearance for Major Depressive Disorder rests on a large, well-established body of research. The evidence specific to postpartum depression is still developing — made up mostly of small trials and meta-analyses of small trials, not the large-scale studies behind the general MDD clearance. That doesn’t mean the early findings aren’t encouraging; it means they should be read as promising rather than definitive.
Because of that, TMS at DTIP is offered under our standard MDD treatment protocol — screening, brain mapping, and provider oversight — rather than as a separately cleared “postpartum depression treatment.” A psychiatric provider will evaluate your history, symptoms, and goals individually to determine whether TMS is an appropriate option for you. Results vary from person to person, and your provider will talk through what’s realistic for you.
Frequently asked questions
A few questions we hear often from new mothers considering TMS. If yours isn’t answered here, our team and your provider are glad to talk it through.
Is TMS safe during breastfeeding?
This is an important question to raise directly with your provider, who can look at your full medical picture. TMS itself is a magnetic stimulation delivered to the scalp and brain, not a medication that circulates through the body, and the studies we’ve reviewed above have not reported disruptions to breastfeeding among participants.
That said, “hasn’t been reported as a problem in small studies” is not the same as “proven safe for breastfeeding” in a large, dedicated way. We won’t claim more certainty than the evidence supports. Your provider will discuss your specific circumstances, including breastfeeding, before recommending a treatment plan.
How is TMS different from medication?
Antidepressant medication works throughout the body and typically needs to build up over weeks. TMS uses magnetic pulses, delivered through a coil placed near the scalp, to stimulate specific brain regions involved in mood regulation during outpatient sessions — it isn’t a pill and isn’t systemic in the way medication is.
TMS is FDA-cleared for adults with Major Depressive Disorder who have not improved on prior antidepressant treatment. For some new mothers, that makes it a meaningful option to discuss, whether alongside medication, instead of it, or after other options haven’t worked as hoped.
When can I start TMS after delivery?
There isn’t a single universal timeline — it depends on your recovery, your symptoms, and your overall health. Your DTIP provider will evaluate your situation at a consultation and determine timing that makes sense for you, in coordination with your OB or midwife as needed.
Is postpartum depression different from the “baby blues”?
Yes. The baby blues are common in the first one to two weeks after delivery and generally ease on their own without treatment. Postpartum depression tends to last longer, feels more intense, and can interfere with daily functioning and bonding. If low mood, anxiety, or hopelessness is sticking around or getting harder to manage, it’s worth talking to a provider — you don’t have to wait for it to become severe.
Will my insurance cover TMS for postpartum depression?
DTIP is in-network with Ambetter and Blue Cross Blue Shield, and coverage for TMS is typically evaluated under your plan’s Major Depressive Disorder benefit, since that’s the basis of TMS’s FDA clearance. Coverage details vary by plan, including any prior treatment history your insurer requires. Our team can verify your specific benefits before you commit to anything.
Ready to find out if TMS is right for you?
Your provider and TMS team determine eligibility. Results vary from person to person.